Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    1734247 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Ampyra for Optic Neuritis in MS
Conditions: Multiple Sclerosis;   Optic Neuritis
Interventions: Drug: Dalfampridine/Placebo;   Drug: Placebo/Dalfampridine
2 Unknown  Longitudinal Optic Neuritis Study (LONS)
Conditions: Multiple Sclerosis;   Optic Neuritis
Interventions: Drug: Methylprednisolone;   Drug: Prednisone
3 Unknown  Optic Neuritis Treatment Trial (ONTT)
Conditions: Multiple Sclerosis;   Optic Neuritis
Interventions: Drug: Methylprednisolone;   Drug: Prednisone

Indicates status has not been verified in more than two years